Drug Type Peptides |
Synonyms- |
Target |
Action inhibitors, agonists |
Mechanism Latent membrane protein 1 inhibitors, PTPRJ agonists(protein tyrosine phosphatase receptor type J agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epstein-Barr virus associated Neoplasms | Preclinical | Malaysia | 07 Oct 2025 |





